Four fragrances, 6-acetyl-1,1,2,4,4,7-hexamethyltetraline (AHTN), 1,3,4,6,7
,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-gamma-2-benzopyran (HHCB), mu
sk ketone and musk xylene were tested for developmental toxicity in Sprague
-Dawley rats (25/group, 3 groups/fragrance, 2 fragrances/corn oil control).
Dosages tested were HHCB: 50, 150, 500 mg/kg per day, AHTN: 5, 15, 50 mg/k
g per day; musk ketone: 15, 45, 150 mg/kg per day; musk xylene: 20, 60, 200
mg/kg per day. All dosages tested exceeded multiples of the estimated maxi
mal daily human dermal exposure. Treatment (gavage, 5 ml/kg) occurred on GD
s 7-17 and Caesarean-sectioning on GD 20. Based on the results of these stu
dies, none of the four fragrances tested were more toxic in the conceptuses
than in the dams. Maternal NOAELs were 50, 5, 15 and 20 mg/kg per day for
HHCB, AHTN, musk ketone and musk xylene, respectively (150, 50, 45 and 60 m
g/kg per day caused clinical signs and reduced weight gain and feed consump
tion). Developmental NOAELs were 150, 50, 45 and 200 mg/kg per day for HHCB
, AHTN, musk ketone and musk xylene, respectively. No adverse effects on em
bryo-fetal viability, growth or morphology occur-red at the highest dosages
of AHTN (50 mg/kg per day) or musk xylene (200 mg/kg per day). Development
al toxicity occurred at the high-dosages of HHCB (axial skeletal malformati
ons at 500 mg/kg per day) and musk ketone (increased postimplantation loss
and reduced fetal body weight at 150 mg/kg per day). The results of this st
udy indicate that under conditions of normal use, the tested fragrances do
not pose a risk to human conceptuses. (C) 1999 Elsevier Science Ireland Ltd
. All rights reserved.